Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_assertion type Assertion NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_head.
- NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_assertion description "[An initial pharmacogenetic study of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) clinical trial reported an association between genetic variation in the HTR2A gene and outcome of citalopram treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_provenance.
- NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_assertion evidence source_evidence_literature NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_provenance.
- NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_assertion SIO_000772 17671280 NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_provenance.
- NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_assertion wasDerivedFrom befree-20140225 NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_provenance.
- NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_assertion wasGeneratedBy ECO_0000203 NP322681.RAc7tbTHFpU3F7kWVT7RaPiCA8xLRNZ0qUB2hy3d_m9AM130_provenance.